secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001770787-25-000040
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics stockholders re-elect Sri Kosaraju and Shehnaaz Suliman as Class III directors
--------------------------------------------------------------------------------

- Kosaraju received 189,313,724 votes for and 7,243,542 against; Suliman 168,973,468 for and 27,595,026 against.
- Ratification of Ernst & Young as independent auditor for FY2025 passed with 215,766,816 votes for.
- Non-binding advisory vote on named executive officer compensation approved with 164,321,765 votes for.
- 108,937,350 shares present or represented by proxy, representing 87.7% of eligible votes, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000177078725000040/0001770787-25-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000177078725000040/txg-20250603.htm
  HTML page:      https://secwatch.observer/filing/0001770787-25-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer